A comparative analysis of TIDE scores indicates significant intergroup differences (p ≈ 5.7 × 10−8), implying that CHK1 may influence tumor immune evasion via increased TIDE scores (Figure 5d,e). The gene discussed is CHEK1; the disease is neoplasm.